Preferential localization of SSEA-4 in interfaces between blastomeres of mouse preimplantaion embryos

Biochemical and Biophysical Research Communications

Volumn 364, Issue 4, 2007, Pages 838-843

  Sato, Ban ^a,c   Katagiri, Yohko U ^a,b   Miyado, Kenji ^a   Akutsu, Hidenori ^a   Miyagawa, Yoshitaka ^a   Horiuchi, Yasuomi ^a   Nakajima, Hideki ^a   Okita, Hajime ^a,b   Umezawa, Akihiro ^a   Hata, Jun ichi ^a   Fujimoto, Junichiro ^a,b   Toshimori, Kiyotaka ^c   Kiyokawa, Nobutaka ^a,b  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Embryonal carcinoma cells; Embryonic stem cells; Immunostaining; Preimplantation embryo; SialylGb5; SSEA 4

Indexed keywords

CERAMIDE; MONOCLONAL ANTIBODY; SIALOSYLGLOBOPENTAOSYLCERAMIDE; STAGE SPECIFIC EMBRYO ANTIGEN 4; UNCLASSIFIED DRUG;

ARTICLE; BLASTOMERE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; THIN LAYER CHROMATOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLASTOCYST; BLASTOMERES; CELL LINE; FEMALE; GLYCOSPHINGOLIPIDS; HAPLORHINI; HUMANS; MALE; MICE;

EID: 36049015104     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.093     Document Type: Article

References (21)

1. Mintz B., and Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 72 (1975) 3585-3589
2. Andrews P.W., Damjanov I., Simon D., Banting G.S., Carlin C., Dracopoli N.C., and Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest. 50 (1984) 147-162
3. Jun-ichi Hata J.F., Ishii E., Umezawa A., Kokai Y., Matsubayashi Y., Abe H., Kusakari S., Kikuchi H., Yamada T., and Maruyama T. Differntiation of human germ cell tumor cells in vivo and in vitro. Acta Histochem. Cytochem. 25 (1992) 563-576
4. Draper J.S., Pigott C., Thomson J.A., and Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200 (2002) 249-258
5. Muramatsu T., and Muramatsu H. Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj. J. 21 (2004) 41-45
6. Nakano T., Umezawa A., Abe H., Suzuki N., Yamada T., Nozawa S., and Hata J. A monoclonal antibody that specifically reacts with human embryonal carcinomas, spermatogonia and oocytes is able to induce human EC cell death. Differentiation 58 (1995) 233-240
7. Yamamoto M., Tase N., Okuno T., Kondo Y., Akiba S., Shimozawa N., and Terao K. Monitoring of gene expression in differentiation of embryoid bodies from cynomolgus monkey embryonic stem cells in the presence of bisphenol A. J. Toxicol. Sci. 32 (2007) 301-310
8. Katagiri Y.U., Ohmi K., Katagiri C., Sekino T., Nakajima H., Ebata T., Kiyokawa N., and Fujimoto J. Prominent immunogenicity of monosialosyl galactosylgloboside, carrying a stage-specific embryonic antigen-4 (SSEA-4) epitope in the ACHN human renal tubular cell line-a simple method for producing monoclonal antibodies against detergent-insoluble microdomains/raft. Glycoconj. J. 18 (2001) 347-353
9. Katagiri Y.U., Kiyokawa N., Nakamura K., Takenouchi H., Taguchi T., Okita H., Umezawa A., and Fujimoto J. Laminin binding protein, 34/67 laminin receptor, carries stage-specific embryonic antigen-4 epitope defined by monoclonal antibody Raft.2. Biochem. Biophys. Res. Commun. 332 (2005) 1004-1011
10. Nakamura K., Hashimoto Y., Suzuki M., Suzuki A., and Yamakawa T. Characterization of GM1b in mouse spleen. J. Biochem. (Tokyo) 96 (1984) 949-957
11. The nomenclature of lipids (recommendations 1976). IUPAC-IUB Commission on Biochemical Nomenclature, J. Lipid. Res. 19 (1978) 114-128.
12. Svennerholm L. Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog. Brain Res. 101 (1994) XI-XIV
13. Cooling L.L., and Kelly K. Inverse expression of P(k) and Luke blood group antigens on human RBCs. Transfusion 41 (2001) 898-907
14. Shevinsky L.H., Knowles B.B., Damjanov I., and Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30 (1982) 697-705
15. Cooling L., and Hwang D. Monoclonal antibody B2, a marker of neuroendocrine sympathoadrenal precursors, recognizes the Luke (LKE) antigen. Transfusion 45 (2005) 709-716
16. Iwabuchi K., and Nagaoka I. Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 100 (2002) 1454-1464
17. Iwabuchi K., Zhang Y., Handa K., Withers D.A., Sinay P., and Hakomori S. Reconstitution of membranes simulating "glycosignaling domain" and their susceptibility to lyso-GM3. J. Biol. Chem. 275 (2000) 15174-15181
18. Kiarash A., Boyd B., and Lingwood C.A. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 269 (1994) 11138-11146
19. Steelant W.F., Kawakami Y., Ito A., Handa K., Bruyneel E.A., Mareel M., and Hakomori S. Monosialyl-Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF-7 cells defines their invasive properties. FEBS Lett. 531 (2002) 93-98
20. Van Slambrouck S., and Steelant W.F. Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells. Biochem. J. 401 (2007) 689-699
21. Comiskey M., and Warner C.M. Spatio-temporal localization of membrane lipid rafts in mouse oocytes and cleaving preimplantation embryos. Dev. Biol. 303 (2007) 727-739